These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28334510)

  • 1. Pharmacokinetics of testosterone cream applied to scrotal skin.
    Iyer R; Mok SF; Savkovic S; Turner L; Fraser G; Desai R; Jayadev V; Conway AJ; Handelsman DJ
    Andrology; 2017 Jul; 5(4):725-731. PubMed ID: 28334510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study.
    Wang C; Berman N; Longstreth JA; Chuapoco B; Hull L; Steiner B; Faulkner S; Dudley RE; Swerdloff RS
    J Clin Endocrinol Metab; 2000 Mar; 85(3):964-9. PubMed ID: 10720024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Study: Absorption of Testosterone Cream via Scrotal Delivery.
    Needham S; Needham S
    Int J Pharm Compd; 2018; 22(6):466-468. PubMed ID: 30384346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial.
    Kühnert B; Byrne M; Simoni M; Köpcke W; Gerss J; Lemmnitz G; Nieschlag E
    Eur J Endocrinol; 2005 Aug; 153(2):317-26. PubMed ID: 16061839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men--a clinical research center study.
    Wang C; Iranmanesh A; Berman N; McDonald V; Steiner B; Ziel F; Faulkner SM; Dudley RE; Veldhuis JD; Swerdloff RS
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2749-57. PubMed ID: 9709942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.
    Meikle AW; Mazer NA; Moellmer JF; Stringham JD; Tolman KG; Sanders SW; Odell WD
    J Clin Endocrinol Metab; 1992 Mar; 74(3):623-8. PubMed ID: 1740497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal testosterone therapy in the treatment of male hypogonadism.
    Ahmed SR; Boucher AE; Manni A; Santen RJ; Bartholomew M; Demers LM
    J Clin Endocrinol Metab; 1988 Mar; 66(3):546-51. PubMed ID: 3350906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.
    Swerdloff RS; Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Longstreth J; Berman N
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4500-10. PubMed ID: 11134099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the steady-state pharmacokinetics, metabolism, and variability of a transdermal testosterone patch versus a transdermal testosterone gel in hypogonadal men.
    Mazer N; Bell D; Wu J; Fischer J; Cosgrove M; Eilers B;
    J Sex Med; 2005 Mar; 2(2):213-26. PubMed ID: 16422889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of a permeation-enhanced testosterone transdermal system in hypogonadal men: influence of application site- -a clinical research center study.
    Meikle AW; Arver S; Dobs AS; Sanders SW; Rajaram L; Mazer NA
    J Clin Endocrinol Metab; 1996 May; 81(5):1832-40. PubMed ID: 8626843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label, phase 2, single centre, randomized, crossover design bioequivalence study of AndroForte 5 testosterone cream and Testogel 1% testosterone gel in hypogonadal men: study LP101.
    Wittert GA; Harrison RW; Buckley MJ; Wlodarczyk J
    Andrology; 2016 Jan; 4(1):41-5. PubMed ID: 26754331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of a transdermal testosterone cream in healthy postmenopausal women.
    Fooladi E; Reuter SE; Bell RJ; Robinson PJ; Davis SR
    Menopause; 2015 Jan; 22(1):44-9. PubMed ID: 24845394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone replacement with transdermal therapeutic systems. Physiological serum testosterone and elevated dihydrotestosterone levels.
    Cunningham GR; Cordero E; Thornby JI
    JAMA; 1989 May; 261(17):2525-30. PubMed ID: 2704112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal testosterone delivery: comparison between scrotal and nonscrotal delivery systems.
    Lin S; Xing QF; Chien YW
    Pharm Dev Technol; 1999 Aug; 4(3):405-14. PubMed ID: 10434286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of three doses of sublingual testosterone in healthy premenopausal women.
    van Rooij K; Bloemers J; de Leede L; Goldstein I; Lentjes E; Koppeschaar H; Olivier B; Tuiten A
    Psychoneuroendocrinology; 2012 Jun; 37(6):773-81. PubMed ID: 21982723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center study.
    Salehian B; Wang C; Alexander G; Davidson T; McDonald V; Berman N; Dudley RE; Ziel F; Swerdloff RS
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3567-75. PubMed ID: 8530600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men.
    Singh AB; Norris K; Modi N; Sinha-Hikim I; Shen R; Davidson T; Bhasin S
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2437-45. PubMed ID: 11397836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioavailability of a new testosterone gel formulation in comparison to Testogel® in healthy men.
    Olsson H; Sandström R; Neijber A; Carrara D; Grundemar L
    Clin Pharmacol Drug Dev; 2014 Sep; 3(5):358-64. PubMed ID: 27129008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of a single dose of buccal testosterone.
    Kim S; Snipes W; Hodgen GD; Anderson F
    Contraception; 1995 Nov; 52(5):313-6. PubMed ID: 8585889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a highly sensitive and selective UPLC/MS/MS method for the simultaneous determination of testosterone and 5alpha-dihydrotestosterone in human serum to support testosterone replacement therapy for hypogonadism.
    Licea-Perez H; Wang S; Szapacs ME; Yang E
    Steroids; 2008 Jul; 73(6):601-10. PubMed ID: 18329061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.